IGNATOVICH; Olga
Patent Applications and Registrations
Patent applications and USPTO patent grants for IGNATOVICH; Olga.The latest application filed is for "anti-cd137 antibodies and methods of use thereof".
Company Profile
7.16.35
- IGNATOVICH; Olga - Cambridge GB
- Ignatovich; Olga - US
- Ignatovich; Olga - Cambridgeshire GB
- Ignatovich; Olga - Abington GB
Patent Activity
| Patent | Date |
|---|---|
| Anti-cd137 Antibodies And Methods Of Use Thereof App 20220235349 - Xiao; Yanping ; et al. | 2022-07-28 |
| Anti-cd137 Antibodies And Methods Of Use Thereof App 20220106581 - XIAO; Yanping ; et al. | 2022-04-07 |
| Antibody Polypeptides That Antagonize Cd40l App 20220073636 - NADLER; Steven G. ; et al. | 2022-03-10 |
| Anti-CD137 antibodies and methods of use thereof Grant 11,242,385 - Xiao , et al. February 8, 2 | 2022-02-08 |
| Antibody polypeptides that antagonize CD40L Grant 11,180,567 - Nadler , et al. November 23, 2 | 2021-11-23 |
| Anti-CD137 antibodies and methods of use thereof Grant 11,098,117 - Xiao , et al. August 24, 2 | 2021-08-24 |
| Anti-cd137 Antibodies And Methods Of Use Thereof App 20210106693 - Xiao; Yanping ; et al. | 2021-04-15 |
| Anti-cd96 Antibodies And Methods Of Use Thereof App 20210101977 - Chand; Dhan Sidhartha ; et al. | 2021-04-08 |
| Compositions Monovalent For Cd28 Binding And Methods Of Use App 20210047414 - McKinnon; Murray ; et al. | 2021-02-18 |
| Compositions monovalent for CD28 binding and methods of use Grant 10,919,965 - McKinnon , et al. February 16, 2 | 2021-02-16 |
| Anti-cd73 Antibodies And Methods Of Use Thereof App 20190352418 - Wilson; Nicholas Stuart ; et al. | 2019-11-21 |
| Antibody Polypeptides That Antagonize Cd40l App 20190100595 - NADLER; Steven G. ; et al. | 2019-04-04 |
| Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40L Grant 10,196,451 - Nadler , et al. Fe | 2019-02-05 |
| Compositions Monovalent For Cd28 Binding And Methods Of Use App 20180142023 - McKinnon; Murray ; et al. | 2018-05-24 |
| Compositions monovalent for CD28 binding and methods of use Grant 9,908,937 - McKinnon , et al. March 6, 2 | 2018-03-06 |
| Antibody Polypeptides That Antagonize Cd40l App 20180051091 - NADLER; Steven G. ; et al. | 2018-02-22 |
| Antibody polypeptides that antagonize CD40L Grant 9,765,150 - Nadler , et al. September 19, 2 | 2017-09-19 |
| Antibody Polypeptides That Antagonize Cd40l App 20160075790 - NADLER; Steven G. ; et al. | 2016-03-17 |
| Antibody polypeptides that antagonize CD40L Grant 9,228,018 - Nadler , et al. January 5, 2 | 2016-01-05 |
| Compositions Monovalent For Cd28 Binding And Methods Of Use App 20150299321 - McKinnon; Murray ; et al. | 2015-10-22 |
| Compositions monovalent for CD28 binding and methods of use Grant 9,085,629 - McKinnon , et al. July 21, 2 | 2015-07-21 |
| Nucleic acids encoding antibody polypeptides that antagonize CD40L Grant 8,981,072 - Nadler , et al. March 17, 2 | 2015-03-17 |
| Antibody Polypeptides That Antagonize Cd40l App 20150023976 - NADLER; Steven G. ; et al. | 2015-01-22 |
| Antibody polypeptides that antagonize CD40L Grant 8,895,010 - Nadler , et al. November 25, 2 | 2014-11-25 |
| Antibody Polypeptides That Antagonize Cd40l App 20140099707 - NADLER; Steven G. ; et al. | 2014-04-10 |
| Compositions and Methods for Treating Inflammatory Disorders App 20130216538 - Ignatovich; Olga ; et al. | 2013-08-22 |
| Compositions monovalent for CD28 binding and methods of use Grant 8,454,959 - McKinnon , et al. June 4, 2 | 2013-06-04 |
| Compositions Monovalent For Cd28 Binding And Methods Of Use App 20130109846 - McKinnon; Murray ; et al. | 2013-05-02 |
| Antibody Polypeptides That Antagonize Cd40l App 20130095109 - NADLER; Steven G. ; et al. | 2013-04-18 |
| Ligands That Have Binding Specificity For Egfr And/or Vegf And Methods Of Use Therefor App 20130041136 - BECKMANN; Roland ; et al. | 2013-02-14 |
| Compositions Monovalent For Cd28 Binding And Methods Of Use App 20120201814 - McKinnon; Murray ; et al. | 2012-08-09 |
| Compositions monovalent for CD28 binding and methods of use Grant 8,168,759 - McKinnon , et al. May 1, 2 | 2012-05-01 |
| Ligand That Has Binding Specificity For Il-4 And/or Il-13 App 20110223168 - Winter; Greg ; et al. | 2011-09-15 |
| Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor Grant 7,696,320 - Ignatovich , et al. April 13, 2 | 2010-04-13 |
| Ligand App 20100081792 - Grant; Steven ; et al. | 2010-04-01 |
| Ligands That Have Binding Specificity For Egfr And/or Vegf And Methods Of Use Therefor App 20100056439 - Beckmann; Roland ; et al. | 2010-03-04 |
| Compositions Monovalent For Cd28 Binding And Methods Of Use App 20100028354 - McKinnon; Murray ; et al. | 2010-02-04 |
| Compositions And Methods For Treating Inflammatory Disorders App 20090258012 - Ignatovich; Olga ; et al. | 2009-10-15 |
| Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor App 20090081233 - Ignatovich; Olga ; et al. | 2009-03-26 |
| Ligands that bind a receptor App 20080241166 - Tomlinson; Ian M. ; et al. | 2008-10-02 |
| Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor App 20070003549 - Ignatovich; Olga ; et al. | 2007-01-04 |
| Retargeting App 20060280734 - Winter; Gregory Paul ; et al. | 2006-12-14 |
| Ligand App 20060257406 - Winter; Greg ; et al. | 2006-11-16 |
| Ligand App 20060106203 - Winter; Greg ; et al. | 2006-05-18 |
| Fc fusion App 20060083747 - Winter; Gregory Paul ; et al. | 2006-04-20 |
| Compositions and methods for treating inflammatory disorders App 20060073141 - Ignatovich; Olga ; et al. | 2006-04-06 |
| Compositions and methods for treating inflammatory disorders App 20050271663 - Ignatovich, Olga ; et al. | 2005-12-08 |
| Dual-specific ligand App 20040219643 - Winter, Greg ; et al. | 2004-11-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 